Crohn's Disease Clinical Trials Crohn's Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition:   Crohn Disease Intervention:   Drug: RVT-3101 Sponsor:   Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition:   Crohn Disease Intervention:   Drug: Infliximab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition:   Crohn Disease Intervention:   Drug: RVT-3101 Sponsor:   Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition:   Crohn Disease Intervention:   Drug: Infliximab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition:   Crohn Disease Intervention:   Drug: RVT-3101 Sponsor:   Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition:   Crohn Disease Intervention:   Drug: Infliximab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition:   Crohn Disease Intervention:   Drug: RVT-3101 Sponsor:   Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition:   Crohn Disease Intervention:   Drug: Infliximab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2023 Category: Research Source Type: clinical trials

TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
Condition:   Crohn Disease Intervention:   Procedure: Magnetic Resonance Enterography (MRE) Sponsor:   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials